Tectonic Advisors »

Halozyme Therapeutics shares owned by Tectonic Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Tectonic Advisors from 13F filings

Historical chart of Tectonic Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Tectonic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Tectonic Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $742k 18k 40.68

More positions owned by Tectonic Advisors

Pimco Etf Tr Active Bd Etf (BOND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ssga Active Etf Tr Spdr Tr Tactic (TOTL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Unified Ser Tr Abslute Selct Vl (ABEQ)
Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Real Estate Etf (VNQ)
Enterprise Products Partners (EPD)

View all positions for Tectonic Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Snyder Capital Management
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
TD Asset Management
Jennifer Ranahan
Arrowpoint Asset Management
Northern Trust
Thrivent Financial for Lutherans
Bank of America Corporation
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics